Market Overview

Harrow Health's Earnings Outlook


On Monday, August 10, Harrow Health (NASDAQ: HROW) will release its latest earnings report. Benzinga's outlook for Harrow Health is included in the following report.

Earnings and Revenue

Based on management's projections, Harrow Health analysts modeled for EPS of $-0.18 per share on sales of $5.70 million. In the same quarter last year, Harrow Health reported EPS of $-0.09 on revenue of $13.52 million. If the company were to report in-line earnings when it publishes results Monday, earnings would be down 100.0%. Sales would be down 51.57% from the year-ago period. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019
EPS Estimate -0.25 0.05 -0.12 -0.07
EPS Actual -0.50 0.10 -0.26 -0.09
Revenue Estimate 11.77 M 13.66 M 12.85 M 12.78 M
Revenue Actual 11.82 M 12.60 M 12.76 M 13.52 M

Stock Performance

Over the past 52-week period, shares of Harrow Health have declined 11.3%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. Harrow Health is scheduled to hold the call at 17:00:00 ET and can be accessed here:


Related Articles (HROW)

View Comments and Join the Discussion!

Posted-In: Earnings